Transaction · 0001437749-26-029121

Rioux Patrice

RIOUX PATRICE, ACMO, reported an open-market or private sale at Monopar Therapeutics involving 1.000000 shares for an estimated $111.26. Reported holdings after the transaction were 5065.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SACMO
MNPRMonopar Therapeutics
Trade date
Aug 26, 2026
Filing date
Aug 27, 2026
View on SEC Insider profile
Estimated value-$111Shares × reported price
Shares traded1$111.26 per share
Holdings after5.06kDirect
% of reported position traded0.02%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 5,066 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MNPR price since this filing

Daily closing prices, with the filing date and available return windows
MNPR · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.8%1w ago +11.4%1d ago +0.0%
Returns since7d +6.6%30d -23.4%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001437749-26-029121
Common Stock
Transaction date
Aug 26, 2026
Filed Aug 27, 2026, 11:29 PM · 1d delay
Shares
1 sh
$111.26 per share
Estimated value
-$111
Computed from shares × price
Holdings after
5,065 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% NoOther Yes
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 27, 2026.

  2. F2

    On December 15, 2016, the reporting person was granted stock options to purchase up to 1,400 shares of common stock vested: 238 shares on January 15, 2017; 224 shares on February 15, 2017; 238 shares…

Original filing · 0001437749-26-029121
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MNPR